ArticleBlood neoplasia2026

Kinetic BCR::ABL1 reduction by transcript types in frontline CML treatment: a GIMEMA LabNet CML network survey.

Fabio Stagno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.